Clinical Trial Update: T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissue and Bone Sarcoma Patients. [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating attIL12-TIL, a T cell therapy engineered with membrane-anchored IL-12, for advanced/metastatic soft tissue and bone sarcoma; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Sarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• attIL12-TIL

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Metastatic Soft-tissue Sarcoma | Phase 1 | Status: RECRUITING